Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
2
×
Tags
biotech
boston blog main
boston top stories
2
×
clinical trials
life sciences
national blog main
national top stories
san francisco blog main
astellas pharma
atlas venture
audentes therapeutics
avidity biosciences
bluebird bio
boston
cancer
cancer drugs
colorectal cancer
duchenne muscular dystrophy
dyne therapeutics
facioscapulohumeral muscular dystrophy
gene therapy
ipo
joshua brumm
kaleido biosciences
mark goldsmith
muscular dystrophy
myotonic dystrophy type 1
new york blog main
non-small cell lung cancer
pancreatic cancer
rare disease drugs
ras
revolution medicines
romesh subramanian
san diego blog main
san francisco
san francisco top stories
sanofi
susanna high
the column group
What
ipo
medicines
reach
2
×
ago
biotechs
cancer
cancer’s
considering
data
disease
diseases
drug
dyne
early
expected
experimental
eyes
frontiers
genetic
having
humans
ipos
known
long
maps
muscle
parlance
pharmaceutical
play
proteins
rare
research
revealed
revolution
role
stopping
therapeutics
way
worked
Language
unset
2
×
Current search:
reach
×
photo
×
unset
×
" boston top stories "
×
@xconomy.com
3 years ago
Dyne Eyes IPO for R&D of Genetic Medicines for Rare Muscle Diseases
@xconomy.com
4 years ago
Revolution Medicines Maps Out an IPO to Reach Cancer’s Frontiers